Are There Benefits for Gestational Diabetes Mellitus in Treating Lower Levels of Hyperglycemia Than Standard Recommendations?

Canadian Journal of Diabetes

Volumn 40, Issue 6, 2016, Pages 548-554

  Nguyen, Thi Hoang Lan ^a   Yang, Ji Wei ^a   Mahone, Michèle ^a   Godbout, Ariane ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

cesarean delivery; diagnostic criteria; gestational diabetes mellitus; gestational weight gain; International Association of Diabetes and Pregnancy Study Groups (IADPSG); macrosomia

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; BODY MASS; CESAREAN SECTION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GESTATIONAL WEIGHT GAIN; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; HYPERGLYCEMIA; INSULIN TREATMENT; MACROSOMIA; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PUERPERIUM; RETROSPECTIVE STUDY; BIRTH WEIGHT; FETAL MACROSOMIA; FOLLOW UP; GLUCOSE TOLERANCE TEST; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; STANDARDS;

ADULT; BIRTH WEIGHT; DIABETES, GESTATIONAL; FEMALE; FETAL MACROSOMIA; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; PRACTICE GUIDELINES AS TOPIC; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 84979567340     PISSN: 14992671     EISSN: 23523840     Source Type: Journal    
DOI: 10.1016/j.jcjd.2016.05.009     Document Type: Article

References (51)

1. 1 Jang, H.C., Cho, N.H., Metzger, B.E., Increased macrosomia and perinatal morbidity independent of maternal obesity and advanced age in Korean women with GDM. Diabetes Care 20 (1995), 1582–1588.
2. 2 O'Sullivan, J.B., Diabetes mellitus after GDM. Diabetes 40:Suppl. 2 (1991), 131–135.
3. 3 Boney, C.M., Verma, A., Tucker, R., et al. Metabolic syndrome in childhood: Association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 115 (2005), e290–6.
4. 4 Danyliv, A., Gillespie, P., Dunne, F., et al. Short- and long-term effects of gestational diabetes mellitus on healthcare cost: A cross-sectional comparative study in the ATLANTIC DIP cohort. Diabet Med 32 (2015), 467–476.
5. 5 O'Sullivan, J.B., Mahan, C.B., Criteria for the oral glucose tolerance test in pregnancy. Diabetes, 13, 1964, 278.
6. 6 National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28 (1979), 1039–1057.
7. 7 Diabetes and pregnancy. In American College of Obstetricians and Gynecologists Technical Bulletin 200, 1994.
8. 8 World Health Orginization Expert Committee on Diabetes Mellitus, 2nd report. World Health Organ Tech Rep Ser 646 (1980), 1–80.
9. 9 Cheng, L.C., Salmon, Y.M., Are the WHO (1980) Criteria for the 75 g oral glucose tolerance test appropriate for pregnant women?. Br J Obstet Gynaecol 100 (1993), 645–648.
10. 10 Pettitt, D.J., Narayan, K.M.V., Bennett, P.H., et al. Comparison of World Health Organization and National Diabetes Data Group procedures to detect abnormalities of glucose tolerance during pregnancy. Diabetes Care 17 (1994), 1264–1268.
11. 11 Reece, E.A., Coustan, D.R., Metabolic changes during normal and diabetic pregnancies. Coustan, DR, (eds.) Diabetes mellitus in pregnancy: Principles and practice, 1988, Churchill Livingston, New York, 75–102.
12. 12 Li, D.F.H., Wong, V.C.W., O'Hoy, K.M., Ma, H.K., Evaluation of the WHO criteria for 75 g oral glucose tolerance test in pregnancy. Br J Obstet Gynaecol 94 (1987), 847–850.
13. 13 Carpenter, M.W., Coustan, D.R., Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 144 (1982), 763–773.
14. 14 Pettitt, D.J., Bennett, P.H., Hanson, R.L., et al. Comparison of World Health Organization and National Diabetes Data Group procedures to detect abnormalities of glucose tolerance during pregnancy. Diabetes Care 17 (1994), 1264–1268.
15. 15 Sacks, D.A., Greenspoon, J.S., Abu-Fadil, S., et al. Toward universal criteria for gestational diabetes: The 75-gram glucose tolerance test in pregnancy. Am J Obstet Gynecol 172 (1995), 607–614.
16. 16 Deerochanawong, C., Putiyanum, C., Wongsuryrat, M., et al. Comparison of National Diabetes Data Group and World Health Organization criteria for detecting gestational diabetes mellitus. Diabetologia 39 (1996), 1070–1073.
17. 17 Metzger, B.E., Coustan, D.R., Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 21:Suppl. 2 (1998), B161–7.
18. 18 Crowther, C.A., Hiller, J.E., Moss, J.R., et al. Effect of treatment of gestational diabetes on pregnancy outcomes. N Engl J Med 352 (2005), 2477–2486.
19. 19 Landon, M.B., Spong, C.Y., Anderson, G.B., et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 361 (2009), 1339–1348.
20. 20 Metzger, E., Lowe, L.P., Dyer, A.R., et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358 (2008), 1991–2002.
21. 21 Metzger, B.E., Gabbe, S.G., Persson, B., et al. International Association of Diabetes and Pregnancy Study Groups recommendation on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33 (2010), 676–682.
22. 22 American Diabetes Association, Standards of medical care in diabetes, 2013. Diabetes Care 36:Suppl. 1 (2013), S11–66.
23. 23 Blumer, I., Hadar, E., Hadden, D., et al. Diabetes and pregnancy: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 98 (2013), 4227–4249.
24. 24 World Health Organization, Diagnostic criteria and classification of hyperglycemia first detected in pregnancy. World Health Organization http://www.who.int/iris/handle/10665/85975, 2013 Accessed April 10, 2015.
25. 25 Canadian Diabetes Association, The Canadian Diabetes Association 2013 Clinical Practice Guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 37 (2013), S168–83.
26. 26 Chang, J., Azziz, R., Legro, R., et al. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 (2004), 19–25.
27. 27 Azziz, R., Carmina, E., Witchel, S.F., et al. The androgen excess and PCOS Society criteria for the polycystic ovary syndrome: The complete task force report. Fertil Steril 91 (2009), 456–488.
28. 28 Rasmussen, K.M., Yaktine, A.L., Institute of Medecine (Committee to Reexamine IOM Pregnancy Weight Guidelines, Food and Nutrition Board and Board on Children, Youth, and Families), (eds.) Weight gain during pregnancy: Reexamining the guidelines, 2009, National Academy Press, Washington.
29. 29 Kramer, M.S., Platt, R.W., Bréart, G., et al. A new and improved population-based Canadian reference for birth weight for gestational age. Fetal/Infant Health Study Group of the Canadian Perinatal Surveillance System. Pediatrics, 108, 2011, e35.
30. 30 Magee, L.A., Helewa, M., Moutquin, J.M., et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can 206 (2008), 1–47.
31. 31 Sibai, B.M., Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 103 (2004), 981–991.
32. 32 Canadian Diabetes Association, The Canadian Diabetes Association 2008 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can J Diabetes 37 (2008), S187–201.
33. 33 Kong, J.M., Lim, K., Thompson, D.M., Evaluation of the International Association of the Diabetes in Pregnancy Study Group New Criteria: Gestational Diabetes Project. Can J Diabetes 39 (2015), 128–132.
34. 34 Gonzalez-Quintero, V.H., Istwan, N.B., Stanziano, G., et al. The impact of glycemic control on neonatal outcome in singleton pregnancies complicated by gestational diabetes. Diabetes Care 3 (2007), 467–470.
35. 35 Johns, K., Olynik, C., Tildesley, H., et al. Gestational diabetes mellitus outcomes in 394 Patients. J Obstet Gynaecol Can 28 (2006), 122–127.
36. 36 Sapienza, A.D., Francisco, R.P.V., Zugaib, M., et al. Factors predicting the need for insulin therapy in patients with gestational diabetes mellitus. Diabetes Res Clin Pract 88 (2010), 81–86.
37. 37 Pertot, T., Molyneaux, L., Wong, J., et al. Can common clinical parameters be used to identify patients who will need insulin treatment in gestational diabetes?. Diabetes Care 34 (2011), 2214–2216.
38. 38 Wong, V.W., Jalaludin, B., Gestational diabetes mellitus: Who requires insulin therapy?. Aust N Z J Obstet Gynaecol 51 (2011), 432–436.
39. 39 Gonzalez-Quintero, V., Istwan, N.B., Stanziano, G.J., Antenatal factors predicting subsequent need for insulin treatment in women with gestational diabetes. J Womens Health (Larchmt) 17 (2008), 1183–1187.
40. 40 Akinci, B., Celtik, A., Yesil, S., et al. Is fasting glucose level during oral glucose tolerance test an indicator of the insulin need in gestational diabetes?. Diabetes Res Clin Pract 82 (2008), 219–225.
41. 41 Retnakaran, R., Qi, Y., Sermer, M., et al. The antepartum glucose values that predict neonatal macrosomia differ from those that predict postpartum prediabetes or diabetes: Implications for the diagnostic criteria for gestation diabetes. J Clin Endocrinol Metab 94 (2009), 840–845.
42. 42 Harville, E.W., Juonala, M., Viikari, J.S.A., et al. Preconception metabolic indicators predict gestational diabetes and offspring birthweight. Gynecol Endocrinol 30 (2014), 840–844.
43. 43 Bethune, M., Bell, R., Evaluation of the measurement of the fetal fat layer, interventricular septum and abdominal circumference percentile in the prediction of macrosomia in pregnancies affected by gestational diabetes. Ultrasound Obstet Gynecol 22 (2003), 586–590.
44. 44 Savitz, D.A., Stein, C.R., Siega-Riz, A.M., et al. Gestational weight gain and birth outcome in relation to prepregnancy body mass index and ethnicity. Ann Epidemiol 21 (2011), 78–85.
45. 45 Witt, W.P., Wisk, L.E., Cheng, E.R., et al. Determinants of cesarean delivery in the US: A lifecourse Approach. Matern Child Health J 19 (2015), 84–93.
46. 46 Ferrara, A., Peng, T., Kim, C., Trends in postpartum diabetes screening and subsequent diabetes and impaired fasting glucose among women with histories of gestational diabetes mellitus. Diabetes Care 32 (2009), 269–274.
47. 47 Lee, A.J., Hiscock, R.J., Permezel, M., et al. Gestational diabetes mellitus: Clinical predictors and long-term risk of developing type 2 diabetes. Diabetes Care 30 (2007), 878–883.
48. 48 Ogonowski, J., Miazgowski, T., The prevalence of 6 weeks postpartum abnormal glucose tolerance in Caucasian women with gestational diabetes. Diabetes Res Clin Prac 85 (2009), 239–244.
49. 49 Catalano, P., McIntyre, H.D., Cruickshank, J.K., et al. The Hyperglycemia and Adverse Pregnancy Outcome Study: Associations of GDM and obesity with pregnancy outcomes. Diabetes Care 35 (2012), 780–786.
50. 50 Lee, J.M., Kim, M.J., Kim, M.H., et al. Gestational weight gain is an important risk factor for excessive fetal growth. Obstet Gynecol Sci 57 (2014), 442–447.
51. 51 Vinturache, A., Melodina, N., Tough, S., et al. Pre-pregnancy body mass index (BMI) and delivery outcomes in a Canadian population. BMC Pregnancy Childbirth 14 (2014), 1–10.